Results 61 to 70 of about 17,596 (164)

Efficacy and safety of adamgammadex for reversing rocuronium‐induced deep neuromuscular blockade: A multicenter, randomized, phase IIb study

open access: yesClinical and Translational Science, Volume 17, Issue 1, January 2024.
Abstract The rapid reversal of deep neuromuscular blockade (NMB) is important but remains challenging. This study aimed to evaluate the efficacy and safety of adamgammadex versus sugammadex in reversing deep rocuronium‐induced NMB. This multicenter, randomized, phase IIb study included 80 patients aged 18–64 years, American Society of Anesthesiologists
Yanhua Zhao   +10 more
wiley   +1 more source

Anesthetic Management and Neuromonitoring in a Patient with Very Long‐Chain Acyl‐Coenzyme A Dehydrogenase Deficiency Undergoing Scoliosis Surgery: A Case Report and Review of Literature

open access: yesCase Reports in Anesthesiology, Volume 2024, Issue 1, 2024.
Patients with very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) are prone to hypoglycemia and clinical decompensation when metabolic demands of the body are not met. We present a pediatric patient with VLCADD who underwent a posterior spinal fusion for scoliosis requiring intraoperative neurophysiology monitoring.
Anna Tanaka   +5 more
wiley   +1 more source

Comparison of Rocuronium and Succinylcholine for First‐Attempt Intubation Success in the Emergency Department

open access: yesJournal of Clinical Pharmacy and Therapeutics, Volume 2024, Issue 1, 2024.
Background. Succinylcholine and rocuronium are the predominant neuromuscular blocking agents (NMBAs) used for rapid sequence intubation (RSI) in the emergency department (ED). Prior studies have found reduced first‐attempt intubation success (FAIS) with rocuronium compared to succinylcholine.
Helen Y. Wang   +5 more
wiley   +1 more source

Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock [PDF]

open access: yes, 2010
Sepsis presents a major health care problem and remains one of the leading causes of death within the intensive care unit (ICU). Therapeutic approaches against severe sepsis and septic shock focus on early identification.
Agwunobi   +119 more
core   +2 more sources

Sugammadex – Reversal of Profound Neuromuscular Blockade in Laparoscopic Surgery [PDF]

open access: yes
Introduction- Sugammadex is a modified γ-cyclodextrin, which promptly reverses the steroidal nondepolarizing neuromuscular blocking agents. Methodology- This interventional trial was commenced after Institutional ethical committee approval in Tagore ...
M. Bastina Jenoffia
core   +2 more sources

Anesthesia management for ALS and WPW [PDF]

open access: yes, 2018
WOS: 000435650500021Epidural anesthesia can provide anesthesia and analgesia for unilateral or bilateral lower extremity surgery and is associated with a low complication rate.
Ekinci, Mürsel   +4 more
core   +1 more source

Effect of priming in shortening onset of pipecuronium, a new nondepolarizing neuromuscular blocker.

open access: yesRevista brasileira de anestesiologia, 2009
One of the most important neuromuscular blockers property is short onset, allowing early tracheal intubation. Low nondepolarizing blocker dose before the full dose is known to decrease the onset of most neuromuscular blockers. Pipecuronium bromide is a long-lasting aminosteroid with major cardiovascular stability, however, with late onset.
José Carlos, Canga   +7 more
openaire   +1 more source

MONITORING NEUROMUSCULAR BLOCKADE AT THE ADDUCTOR POLLICIS AND ORBICULARIS OCULI WITH SPLIT DOSING OF MIVACURIUM CHLORIDE [PDF]

open access: yes, 1994
Twenty ASA class I and II patients between the ages of 15 and 64 years undergoing surgical procedures requiring neuromuscular blockade and general anesthesia were selected at random to participate in this study.
Palmerton, Stephen F.
core   +1 more source

Cost-Efficiency of Sugammadex Versus Neostigmine/Robinul in Reversing Neuromuscular Blockade [PDF]

open access: yes, 2019
As healthcare costs in the United States continue to rise, healthcare providers must do their part to negate the expenses incurred by hospitals and patients.
Fryfogle, Joel
core   +1 more source

Rocuronium and Malignant Hyperthermia [PDF]

open access: yes, 2012
Authors response to a comment on: Beggs A, McCann J, Powers J. “Delayed-onset malignant hyperthermia in association with rocuronium use ” Am J Health-Syst Pharm 2012; 69:1128 ...
Beggs, Ashton E., McCann, Jennifer Quinn
core   +2 more sources

Home - About - Disclaimer - Privacy